Mechanosensing regulates pDC activation in the skin through NRF2 activation
Journal of Experimental Medicine · 03.03.2025 · 222 (3)
DOI: 10.1084/jem.20240852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 13.12.2024. Verfasst von Vidyanath Chaudhary und 6 weiteren Autor:innen. Beteiligte Einrichtung: HSS Research Institute, Inflammation and Autoimmunity Program, Hospital for Special Surgery , New York, NY, USA. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Skin, Dendritic Cells, Interferon Type I. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, Scleroderma Research Foundation.
Abstract (Originalsprache)
Plasmacytoid DCs (pDCs) infiltrate the skin, chronically produce type I interferon (IFN-I), and promote skin lesions and fibrosis in autoimmune patients. However, what controls their activation in the skin is unknown. Here, we report that increased stiffness inhibits the production of IFN-I by pDCs. Mechanistically, mechanosensing activates stress pathways including NRF2, which induces the pentose phosphate pathway and reduces pyruvate levels, a product necessary for pDC responses. Modulating NRF2 activity in vivo controlled the pDC response, leading to resolution or chronic induction of IFN-I in the skin. In systemic sclerosis (SSc) patients, although NRF2 was induced in skin-infiltrating pDCs, as compared with blood pDCs, the IFN response was maintained. We observed that CXCL4, a profibrotic chemokine elevated in fibrotic skin, was able to overcome stiffness-mediated IFN-I inhibition, allowing chronic IFN-I responses by pDCs in the skin. Hence, these data identify a novel regulatory mechanism exerted by the skin microenvironment and identify points of dysregulation of this mechanism in patients with skin inflammation and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HSS Research Institute, Inflammation and Autoimmunity Program, Hospital for Special Surgery , New York, NY, USA.
- Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, NY, USA.
- Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medicine , New York, NY, USA.
- David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery , New York, NY, USA.
- Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
- Mary Kirkland Center for Lupus Research, Hospital for Special Surgery , New York, NY, USA.
ORCID-Profile: Vidyanath Chaudhary, Bikash Mishra, Marie Dominique Ah Kioon, Yong Du, Lionel B Ivashkiv, Mary K Crow, Franck J Barrat
Förderung
- NIAID NIH HHS
- NIH HHS
- Scleroderma Research Foundation
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Chaudhary, V., Mishra, B., Ah Kioon, M. D., Du, Y., Ivashkiv, L. B., Crow, M. K., & Barrat, F. J. (2025). Mechanosensing regulates pDC activation in the skin through NRF2 activation. Journal of Experimental Medicine, 222(3). https://doi.org/10.1084/jem.20240852
Vancouver
Chaudhary V, Mishra B, Ah Kioon MD, Du Y, Ivashkiv LB, Crow MK, et al. Mechanosensing regulates pDC activation in the skin through NRF2 activation. Journal of Experimental Medicine. 2025;222(3). doi:10.1084/jem.20240852
BibTeX
@article{Chaudhary2025,
author = {Chaudhary, Vidyanath and Mishra, Bikash and Ah Kioon, Marie Dominique and Du, Yong and Ivashkiv, Lionel B and Crow, Mary K and Barrat, Franck J},
title = {Mechanosensing regulates pDC activation in the skin through NRF2 activation},
journal = {Journal of Experimental Medicine},
year = {2025},
volume = {222},
number = {3},
doi = {10.1084/jem.20240852}
}
EUVIMED